Pharmaceutical development of medicines for paediatric use

This document provides guidance on the pharmaceutical development of medicinal products for children between birth and 18 years of age.

Keywords: Pharmaceutical development, quality, child, paediatric formulation, paediatric investigation plan (PIP)

How useful was this page?

Add your rating
Average
1 rating